highly variable drugs [Bioanalytics]

posted by drgunasakaran1  – 2011-02-13 16:29 (5611 d 12:03 ago) – Posting: # 6623
Views: 6,088

Dear Mr.Mustafa,

Check out the CHMP assessment report on Lamivudine which discuss about the intrasubject CV% in a bioequivalence study in the following link
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001111/WC500044180.pdf

Find the intrasubject CV% of Simvastatin and Itraconazole in the Public assessment report of Itraconazole and Simvastatin in the following links
http://www.lakemedelsverket.se/SPC_PIL/Pdf/par/Simvastatin%20Morningside,%20film-coated%20tablets.pdf
http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con046562.pdf

Regards,

Dr.S.Gunasakaran, MD

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
105 visitors (0 registered, 105 guests [including 13 identified bots]).
Forum time: 05:32 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5